Buruli ulcer

A chronic debilitating skin and soft tissue infection

Buruli ulcer
Buruli ulcer.jpg
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	N/A
Complications	N/A
Onset	N/A
Duration	N/A
Types	N/A
Causes	N/A
Risks	N/A
Diagnosis	N/A
Differential diagnosis	N/A
Prevention	N/A
Treatment	N/A
Medication	N/A
Prognosis	N/A
Frequency	N/A
Deaths	N/A

Buruli ulcer is a chronic, debilitating skin and soft tissue infection caused by the bacterium Mycobacterium ulcerans. It is characterized by the development of large ulcers, primarily on the limbs, and can lead to significant morbidity if not treated appropriately.

Epidemiology

Buruli ulcer is most commonly found in rural areas of West Africa, Central Africa, and some parts of Australia. It is considered a neglected tropical disease and primarily affects children and young adults. The exact mode of transmission is not well understood, but it is believed to be associated with environmental factors, particularly aquatic environments.

Pathophysiology

The disease is caused by Mycobacterium ulcerans, which produces a toxin known as mycolactone. This toxin is responsible for the tissue necrosis and immunosuppression observed in Buruli ulcer. The infection typically begins as a painless nodule or papule, which can progress to a large ulcer with undermined edges.

Clinical Presentation

The initial presentation of Buruli ulcer is often a painless, firm nodule or plaque. Over time, this lesion can ulcerate, leading to the characteristic large, necrotic ulcer with undermined edges. The ulcers are typically painless, but secondary bacterial infections can cause pain and further complications. The disease primarily affects the skin and soft tissues, but in severe cases, it can involve bones.

Diagnosis

Diagnosis of Buruli ulcer is primarily clinical, supported by laboratory tests. Polymerase chain reaction (PCR) testing for Mycobacterium ulcerans DNA is the most sensitive method. Other diagnostic methods include microscopy, culture, and histopathology. Early diagnosis is crucial for effective treatment and to prevent complications.

Treatment

The mainstay of treatment for Buruli ulcer is a combination of antibiotics, typically rifampicin and clarithromycin or streptomycin. Surgical intervention may be necessary for extensive lesions, including debridement and skin grafting. Early treatment is essential to prevent severe tissue damage and disability.

Prevention

Preventive measures for Buruli ulcer are not well established due to the unclear mode of transmission. However, efforts to reduce exposure to potential environmental sources, such as stagnant water, may help reduce the risk. Community education and early case detection are important components of prevention strategies.

Related pages

• Mycobacterium ulcerans
• Neglected tropical diseases
• Skin infections